©2012 Baishideng Publishing Group Co.
World J Radiol. Jul 28, 2012; 4(7): 318-323
Published online Jul 28, 2012. doi: 10.4329/wjr.v4.i7.318
Published online Jul 28, 2012. doi: 10.4329/wjr.v4.i7.318
Table 1 Patients’ and tumors’ characteristics
| Characteristics | |
| Number of patients | 66 |
| Median age in years (range) | 80 (56-92) |
| Stage, n (%) | |
| I | 28 (42.4) |
| II | 23 (34.8) |
| III | 10 (18) |
| IV | 5 (5) |
| Histological type, n (%) | |
| Invasive ductal carcinoma | 54 (81.8) |
| Invasive lobular carcinoma | 11 (16.6) |
| Other histology | 1 (1.6) |
| Grade, n (%) | |
| 1 | 15 (22.7) |
| 2 | 38 (57.6) |
| 3 | 11 (16.6) |
| NR | 2 (3.1) |
| Mitotic index, n (%) | |
| Low | 42 (63.6) |
| Intermediate | 11 (16.7) |
| High | 7 (10.6) |
| NR | 6 (9.1) |
| Expression of endocrine receptors, % (median) | |
| ER | 100 (60-100) |
| PgR | 100 (60–100) |
| HER2 status, n (%) | |
| Positive | 11 (16.6) |
| Negative | 55 (83.4) |
- Citation: Chargari C, Castro-Pena P, Toledano I, Bollet MA, Savignoni A, Cottu P, Laki F, Campana F, Fourquet A, Kirova YM. Concurrent use of aromatase inhibitors and hypofractionated radiation therapy. World J Radiol 2012; 4(7): 318-323
- URL: https://www.wjgnet.com/1949-8470/full/v4/i7/318.htm
- DOI: https://dx.doi.org/10.4329/wjr.v4.i7.318